PETMED EXPRESS INC
For the period ended Mar 31, 2025. Filed Oct 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Oct 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: October 14, 2025
| PETMED EXPRESS, INC. | |
| (the “registrant”) | |
| By: | /s/ Leslie Campbell |
| Leslie Campbell | |
| Interim Chief Executive Officer and President | |
| (principal executive officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on October 14, 2025.
| SIGNATURE | TITLE |
|---|---|
| /s/ Leslie C.G. Campbell | Interim Chief Executive Officer and President (principal executive officer) |
| Leslie C.G. Campbell | |
| /s/ Doug Krulik | Chief Accounting Officer and Interim Principal Financial Officer and Treasurer (principal financial and accounting officer) |
| Doug Krulik | |
| /s/ Gian M. Fulgoni | Director |
| Gian M. Fulgoni | |
| /s/ Justin Mennen | Director |
| Justin Mennen | |
| /s/ Leah Solivan | Director |
| Leah Solivan | |
| /s/ Peter Batushansky | Director |
| Peter Batushansky | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.